Yayın: Pegylatedd interferon alfa-2b monotherapy and pegylated interferon alfa-2b plus lamivudine combination therapy for patients with hepatitis B virus E antigen-negative chronic hepatitis B
Dosyalar
Tarih
Kurum Yazarları
Yazarlar
Kaymakoglu, Sabahattin
Oğuz, Dilek
Gür, Gürden
Gürel, Selim
Tankurt, Ethem
Ersöz, Galip
Özenirler, Seren
Kalaycı, Cem
Poturoğlu, Şule
Çakaloğlu, Yılmaz
Danışman
Dil
Türü
Yayıncı:
Amer Soc Microbiology
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Özet
Forty-eight hepatitis B virus (HBV) E antigen-negative chronic hepatitis B patients received pegylated interferon alfa-2b either alone or with lamivudine for 48 weeks and were followed for an additional 24 weeks. At the end of follow-up, virological response rates (HBV DNA levels of < 400 copies/ml) were similar in the monotherapy (24%) and combination therapy (26%) groups.
Açıklama
Kaynak:
Anahtar Kelimeler:
Konusu
Microbiology, Pharmacology & pharmacy